Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction

Current Biology

Volumn 8, Issue 10, 1998, Pages 563-573

  Holsinger, L J ^a   Graef, I A ^a   Swat, W ^b   Chi, T ^a   Bautista, D M ^c   Davidson, L ^b   Lewis, R S ^c   Alt, F W ^b   Crabtree, G R ^a  

^a STANFORD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0032493028     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70225-8     Document Type: Article

References (51)

1. Katzav S, Martin-Zanca D, Barbacid M: vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 1989, 8:2283-2290.
2. Puil L, Pawson T: Vagaries of Vav. Curr Biol 1992, 2:275-277.
3. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995, 374:470-473.
4. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, et al.: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995, 374:467-470.
5. + thymocytes. Nature 1995, 374:474-477.
6. Wu J, Katzav S, Weiss A: A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol 1995, 15:4337-4346.
7. Wu J, Motto DG, Koretsky GA, Weiss A: Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 1996, 4:593-602.
8. Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR: Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA 1995, 92:9810-9814.
9. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997, 385:169-172.
10. Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
11. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
12. Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81:53-62.
13. Chong LD, Traynor Kaplan A, Bokoch GM, Schwartz MA: The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell 1994, 79:507-513.
14. Hartwig JH, Bokoch GM, Carpenter CL, Janmey PA, Taylor LA, Toker A, Stossel TP: Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 1995, 82:643-653.
15. Tolias KF, Cantley LC, Carpenter CL: Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 1995, 270:17656-17659.
16. Minden A, Lin A, Claret FX, Abo A, Karin M: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995, 81:1147-1157.
17. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, et al.: The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81:1137-1146.
18. Lamarche N, Tapon N, Stowers L, Burbelo PD, Aspenstrom P, Bridges T, et al.: Rac and Ccd42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase kinase. Cell 1996, 87:519-529.
19. Joneson T, McDonough M, Bar-Sagi D, van Aelst L: Rac regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science 1996, 274:1374-1376.
20. Olson MF, Pasteris NG, Gorski JL, Hall A: Faciogenital dysplasia protein (FDG1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr Biol 1996, 6:1628-1633.
21. Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M, et al.: Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by vav. Oncogene 1996, 13:455-460.
22. Bustelo XR, Suen KL, Leftheris K, Meyers CA, Barbacid M: Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/ GTP exchange factor. Oncogene 1994, 9:2405-2413.
23. de Petris S, Raff MC: Normal distribution, patching and capping of lymphocyte surface immunoglobulin studied by electron microscopy. Nature New Biol 1973, 241:257-259.
24. de Petris S: Inhibition and reversal of capping by cytochalasin B, vinblastine and colchicine. Nature 1974, 250:54-56.
25. Unanue ER, Perkins WD, Karnovsky MJ: Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med 1972, 136:885-906.
26. Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A: Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med 1995, 181:577-584.
27. Monks CRF, Kupfer H, Tamir I, Barlow A, Kupfer A: Selective modulation of protein kinase C-theta during T-cell activation. Nature 1997, 385:83-86.
28. Chan AC, Irving BA, Fraser JD, Weiss A: The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991, 88:9166-9170.
29. Graziadei L, Riabowol K, Bar-Sagi D: Co-capping of ras proteins with surface immunoglobulins in B lymphocytes. Nature 1990, 347:396-400.
30. Fischer K-D, Kong Y-Y, Nishina H, Tedford K, Marengere LEM, Kozieradzki I, et al.: Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr Biol 1998, 8:554-562
31. Clipstone NA, Crabtree GR: Identification of calcineurin as a key signalling enzyme in T cell activation. Nature 1992, 357:695-697.
32. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
33. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991, 352:803-807.
34. Turner M, Mee J, Walters AE, Quinn ME, Mellor AL, Zamoyska R, Tybulewicz VLJ: A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 1997, 7:451-460.
35. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA: Stimulation of p21ras upon T-cell activation. Nature 1990, 346:719-723.
36. Swan KA, Alberola-IIa J, Gross JA, Appleby MW, Forbush KA, Thomas JF, et al.: Involvement of p21 ras distinguishes positive and negative selection in thymocytes. EMBO J 1995, 14:276-285.
37. + thymocytes. Proc Natl Acad Sci USA 1996, 93:4683-4687.
38. Wolfe SA, Zhou P, Dötsch V, Chen L, You A, Ho SN, et al.: Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature 1997, 385:172-176.
39. Crabtree GR. Contigent genetic regulatory events in T lymphocyte activation. Science 1989, 243:355-361.
40. Genot E, Cleverley S, Henning S, Cantrell D: Multiple p21ras efffector pathways regulate nuclear factor of activated T cells. EMBO J 1996, 15:3923-3933.
41. Braun J, Fujiwara K, Pollard TD, Unanue ER: Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol 1978, 79:409-418.
42. Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, et al.: Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996, 84:723-734.
43. Kolluri R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T: Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 1996, 93:5615-5618.
44. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold ODE: T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol 1993, 151:4383-4390.
45. Stowers L, Yelon D, Berg LJ, Chant J: Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42. Proc Natl Acad Sci USA 1995, 92:5027-5031.
46. Zipkin ID, Kindt RM, Kenyon CJ: Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell 1997, 90:883-894.
47. 2+ signals and immunosuppression. Nature 1996, 383:837-840.
48. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 1996, 273:104-106.
49. Serafini AT, Lewis RS, Clipstone NA, Bram RJ, Fanger C, Fiering S, et al.: Isolation of mutant T lymphocytes with defects in capacitative calcium entry. Immunity 1995, 3:239-250.
50. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucl Acids Res 1984, 12:7035-7056.
51. Fiering S, Northrop JP, Nolan GP, Mattila PS, Crabtree GR, Herzenberg LA: Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev 1990, 4:1823-1834.